The company's financial results
In yesterday's trading, Walgreens shares opened at US$47.82 and closed at US$47.46, losing -0.75%. Also, the company's highest price per share was US$48.48 and the lowest was US$47.29.
At the close of trading, the company's Volume was 8,034,400. It is worth noting that Avg. Volume of the company is 6,621,131.
Also, over the last five days, the company's shares added +1.13%.
Walgreens Boots Alliance currently has a market capitalisation of $40.97 billion.
The company has a 52-week high of $57.05 and a 52-week low of $43.62.
Report from the pharmacy company
In its Q2nd financial results report, Walgreens reported Earnings Per Share (EPS) from continuing operations in Q2 was US$1.02. This result is $0.04 less than in Q2 last year.
The company's sales from continuing operations in Q2nd rose 3.0% to $33.8 billion compared to Q2nd last year.
Operating profit from the company's continuing operations in Q2nd increased to USD 1.2 billion. It is worth noting that in the previous fiscal year it was US$832 million. Also, adjusted operating profit from continuing operations increased to USD 1.7 billion.
Walgreens Boots Alliance Company's comparable U.S. retail sales increased 14.7%.
Walgreens Health pre-sales were up 128%.
Walgreens Boots Alliance was founded in 2014.
Board of directors:
Stefano Pessina - Executive Chairman;
Rosalind Brewer - CEO;
Janice Babiak - Former Managing Partner, Ernst and Young;
David Brailer - Chairman, Health Evolution Partners;
William Foote - Lead Independent Director;
Ginger Graham - Former President and CEO of Amylin Pharmaceuticals;
Valerie Jarrett - Former Senior Advisor to President Barack Obama;
John Lederer - Senior Advisor of Sycamore Partners;
Dominic Murphy - Co-Head of UK Investments, CVC Capital Partners;
Nancy Schlichting - Former CEO of Henry Ford Health System;
Steven Shulman - Chairman of CareCentrix and LD of VillageMD.